Fig. 12From: Integrated analysis of the relation to tumor immune microenvironment and predicted value of Stonin1 gene for immune checkpoint blockage and targeted treatment in kidney renal clear cell carcinomaThe sensitivity for five targeted agents among the two groups in KIRC. High, high expression of STON1 group; low, low expression of STON1 group; the vertical axis represents the distribution of IC50 scores; ***P < 0.001, ****P < 0.0001Back to article page